• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部侵犯胃癌的手术影响。

Surgical impact on gastric cancer with locoregional invasion.

机构信息

Department of Surgery, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei, 11217, Taiwan.

出版信息

World J Surg. 2011 Nov;35(11):2479-84. doi: 10.1007/s00268-011-1246-9.

DOI:10.1007/s00268-011-1246-9
PMID:21882020
Abstract

BACKGROUND

The benefit of resection of gastric cancer with locoregional invasion is still under debate. This study aimed to investigate the impact of surgery on patients with gastric cancer with locoregional invasion.

METHODS

From January 1988 to December 2009, a total of 2,678 patients with gastric cancer underwent surgery at the Department of Surgery, Taipei Veterans General Hospital. Among these patients, 569 and 295 were diagnosed as T4a (serosa invasion without penetration of visceral peritoneum) and T4b (serosa exposure with invasion of adjacent structure), respectively. Invasion type and prognosis were analyzed in patients with gastric cancer who had either curative or palliative resection.

RESULTS

Our results showed that patients with T4a gastric cancer had a better 5-year overall survival than patients with T4b (22.5% vs. 11.5%, P < 0.001). Patients with T4b who had curative resection had a better 5-year overall survival than those with T4b who had palliative resection (13.8% vs. 7.3%, P = 0.001). The prognosis of patients with gastric cancer with pancreas invasion was worse than those with mesocolon invasion, as no patients with pancreas invasion survived more than 5 years. Univariate and multivariate analyses showed that tumor size (P = 0.019), Bormann classification (P < 0.001), stromal reaction (P = 0.001), and nodal involvement (P < 0.001) were independent predictors for overall survival in patients with T4b gastric cancer.

CONCLUSION

Resection of T4b gastric cancer could be performed with curative intent. Patients with gastric cancer with pancreas invasion had a poorer prognosis than those with mesocolon invasion.

摘要

背景

局部侵犯的胃癌行切除术的获益仍存在争议。本研究旨在探讨手术对局部侵犯的胃癌患者的影响。

方法

1988 年 1 月至 2009 年 12 月,台北荣民总医院外科共对 2678 例胃癌患者进行了手术。其中,569 例和 295 例分别被诊断为 T4a(浆膜侵犯而无内脏腹膜穿透)和 T4b(浆膜暴露伴邻近结构侵犯)。分析了行根治性或姑息性切除术的胃癌患者的侵犯类型和预后。

结果

我们的结果表明,T4a 胃癌患者的 5 年总生存率优于 T4b 患者(22.5% vs. 11.5%,P < 0.001)。行根治性切除术的 T4b 患者的 5 年总生存率优于姑息性切除术的 T4b 患者(13.8% vs. 7.3%,P = 0.001)。胰腺侵犯的胃癌患者的预后比结系膜侵犯的患者差,因为没有胰腺侵犯的患者生存时间超过 5 年。单因素和多因素分析显示,肿瘤大小(P = 0.019)、Bormann 分类(P < 0.001)、间质反应(P = 0.001)和淋巴结受累(P < 0.001)是 T4b 胃癌患者总生存的独立预测因素。

结论

T4b 胃癌的切除术可达到根治性目的。胰腺侵犯的胃癌患者的预后比结系膜侵犯的患者差。

相似文献

1
Surgical impact on gastric cancer with locoregional invasion.局部侵犯胃癌的手术影响。
World J Surg. 2011 Nov;35(11):2479-84. doi: 10.1007/s00268-011-1246-9.
2
[Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].[Borrmann Ⅳ型(全胃癌)的外科治疗与预后]
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Feb 25;21(2):185-189.
3
Serosa-penetration in human T4aN0M0 gastric carcinoma correlates with worse prognosis after D2 gastrectomy.人类 T4aN0M0 胃癌的浆膜穿透与 D2 胃切除术后的预后较差相关。
Chin Med J (Engl). 2012 Mar;125(6):1158-62.
4
Prognosis of curatively resected pT4b gastric cancer with respect to invaded organ type.根治性切除的 pT4b 胃癌的预后与侵犯器官类型有关。
Ann Surg Oncol. 2012 Feb;19(2):494-501. doi: 10.1245/s10434-011-1987-6. Epub 2011 Aug 12.
5
Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.淋巴结阴性的进展期胃癌的预后因素和复发模式。
Eur J Surg Oncol. 2013 Feb;39(2):136-40. doi: 10.1016/j.ejso.2012.10.008. Epub 2012 Nov 11.
6
Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer.Ⅱ期胃癌中淋巴管和/或血管侵犯的影响。
World J Gastroenterol. 2012 Jul 21;18(27):3610-6. doi: 10.3748/wjg.v18.i27.3610.
7
Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study.多脏器切除术治疗局部进展期胃癌:一项意大利多中心观察性研究。
JAMA Surg. 2013 Apr;148(4):353-60. doi: 10.1001/2013.jamasurg.309.
8
Prognosis of gastric carcinoma invading the mesocolon.
Asian J Surg. 2008 Oct;31(4):179-84. doi: 10.1016/S1015-9584(08)60082-2.
9
Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection.潜在可治愈性切除的 T4 期胃癌患者的预后因素。
World J Gastroenterol. 2011 Mar 7;17(9):1180-4. doi: 10.3748/wjg.v17.i9.1180.
10
Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.胃 T4a 癌浆膜侵犯亚组对患者生存的影响。
In Vivo. 2022 Jul-Aug;36(4):1923-1929. doi: 10.21873/invivo.12913.

引用本文的文献

1
A Comparative Analysis of Laparoscopic Gastrectomy Versus Laparoscopic-Assisted Gastrectomy: The Overall and Disease-Free Survival.腹腔镜胃切除术与腹腔镜辅助胃切除术的比较分析:总生存率和无病生存率
Cureus. 2024 Mar 22;16(3):e56730. doi: 10.7759/cureus.56730. eCollection 2024 Mar.
2
Short-term safety and Long-term efficacy of multivisceral resection in pT4b gastric cancer patients without distant metastasis: a 20-year experience in China National Cancer Center.多脏器切除治疗无远处转移的pT4b期胃癌患者的短期安全性和长期疗效:中国国家癌症中心20年经验
J Cancer. 2022 Aug 15;13(10):3113-3120. doi: 10.7150/jca.75456. eCollection 2022.
3

本文引用的文献

1
Palliative resection in noncurative gastric cancer patients.姑息性切除在不可治愈的胃癌患者中的应用。
World J Surg. 2010 May;34(5):1015-21. doi: 10.1007/s00268-010-0467-7.
2
Should direct mesocolon invasion be included in T4 for the staging of gastric cancer?胃肿瘤分期中是否应将结肠直接侵犯纳入 T4?
J Surg Oncol. 2010 Mar 1;101(3):205-8. doi: 10.1002/jso.21476.
3
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer.
Peri-operative Outcomes and Survival Following Palliative Gastrectomy for Gastric Cancer: a Systematic Review and Meta-analysis.
胃癌姑息性胃切除术后的围手术期结局与生存:一项系统评价和荟萃分析
J Gastrointest Cancer. 2021 Mar;52(1):41-56. doi: 10.1007/s12029-020-00519-4. Epub 2020 Sep 22.
4
Extended Gastrectomy for T4b Gastric Adenocarcinoma: Single-Surgeon Experience.T4b期胃腺癌的扩大根治性胃切除术:单中心经验
J Gastrointest Cancer. 2020 Mar;51(1):135-143. doi: 10.1007/s12029-019-00222-z.
REAL-2和ML17032试验的荟萃分析:评估以卡培他滨为基础的联合化疗和以静脉输注5-氟尿嘧啶为基础的联合化疗用于治疗晚期食管胃癌。
Ann Oncol. 2009 Sep;20(9):1529-1534. doi: 10.1093/annonc/mdp047. Epub 2009 May 27.
4
Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.将IV期胃癌进一步细分为IVA、IVB和IVM期的提议。
Arch Surg. 2009 Jan;144(1):38-45; discussion 45. doi: 10.1001/archsurg.2008.502.
5
Prognosis of gastric carcinoma invading the mesocolon.
Asian J Surg. 2008 Oct;31(4):179-84. doi: 10.1016/S1015-9584(08)60082-2.
6
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.S-1联合顺铂与单用S-1作为晚期胃癌一线治疗的疗效比较(SPIRITS试验):一项III期试验
Lancet Oncol. 2008 Mar;9(3):215-21. doi: 10.1016/S1470-2045(08)70035-4. Epub 2008 Feb 20.
7
Capecitabine and oxaliplatin for advanced esophagogastric cancer.卡培他滨与奥沙利铂用于晚期食管胃癌
N Engl J Med. 2008 Jan 3;358(1):36-46. doi: 10.1056/NEJMoa073149.
8
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine.使用口服氟嘧啶S-1对胃癌进行辅助化疗。
N Engl J Med. 2007 Nov 1;357(18):1810-20. doi: 10.1056/NEJMoa072252.
9
Nodal dissection for patients with gastric cancer: a randomised controlled trial.胃癌患者的淋巴结清扫:一项随机对照试验。
Lancet Oncol. 2006 Apr;7(4):309-15. doi: 10.1016/S1470-2045(06)70623-4.
10
Surgical outcomes in patients with T4 gastric carcinoma.T4期胃癌患者的手术治疗结果
J Am Coll Surg. 2006 Feb;202(2):223-30. doi: 10.1016/j.jamcollsurg.2005.10.020.